EXACT Sciences Corp (EXAS)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

441 CHARMANY DRIVE MADISON, WI 53719

Applies its proprietary DNA-based technologies to the early detection of cancer. The company's first major commercial application is PreGen-Plus, a non-invasive DNA-based test for the early detection of colorectal cancer.

Data based on most recent fiscal year report
Market Cap4.837 Billion Shares Outstanding119.73 Million Avg Volume3.966 Million
1-Yr BETA vs S&P TR Current Ratio7.15 Quick Ratio6.77
View SEC Filings from EXAS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade EXAS now:
Filers who had this stock in their top 10: 8 4 (0.41%)
13F Filers holding this stock: 456 43 (4.44%)
Aggregate 13F shares on 06/30/2019: 113.185 Million 10.418 Million
Aggregate 13F shares on 03/31/2019: 111.463 Million 13.65 Million
Percent change: 1.54% -23.67%
Funds creating new positions: 101 9
Funds Adding to an existing position: 138 12
Funds closing out their position: 51 13
Funds reducing their position: 144 17
Heat Map Ranking for 06/30/2019 31
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EXAS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

7.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CONROY KEVIN T

  • Director
5,740 2019-09-30 7

BAKEWELL JOHN K

  • Director
31,597 2019-09-24 0

ZENNER PATRICK J

  • Director
122,216 2019-09-24 0

ELLIOTT JEFFREY THOMAS

  • Director
0 2019-09-18 6

JOHNSON SCOTT C. SVP - RESEARCH AND DEVELOPMENT

  • Officer
12,504 2019-09-11 4

SEBELIUS KATHLEEN

  • Director
0 2019-08-23 3

LEVANGIE DANIEL J

  • Director
12,458 2019-07-31 3

ZANOTTI KATHERINE S

  • Director
77,513 2019-07-31 4

CAREY THOMAS D.

  • Director
34,181 2019-07-31 3

DOYLE JAMES EDWARD

  • Director
34,440 2019-07-31 3

WYZGA MICHAEL S

  • Director
8,913 2019-07-31 3

CASDIN ELI

  • Director
6,262 2019-07-25 1

SLAVITT ANDREW M

  • Director
5,387 2019-07-25 2

JACQUET PIERRE

  • Director
0 2019-07-25 2

CRAWFORD SALLY

  • Director
28,469 2019-05-30 0

FALLON JOHN A.

  • Director
13,469 2019-05-30 0

WILLSEY LANCE

  • Director
0 2019-05-23 0

KANIA EDWIN M JR

  • Director
1,285,280 2019-05-06 0

HOOKER ANA SVP, OPERATIONS

  • Officer
76,474 2019-04-24 1

STENHOUSE MARK PRESIDENT, COLOGUARD

  • Officer
14,471 2019-04-02 3

COWARD D SCOTT CHIEF ADMINISTRATIVE OFFICER

  • Officer
106,978 2019-03-09 6

THOMPSON DAVID

  • Director
166,671 2018-12-31 1

LIDGARD GRAHAM PETER CHIEF SCIENCE OFFICER

  • Officer
41,040 2018-11-05 2

ARORA MANEESH COO

  • Officer
  • Director
658,613 2018-03-09 0

STERLING LIONEL

  • Director
127,575 2017-07-27 0

LUBER JEFFREY R

  • Director
0 2016-02-04 0

MEGAN WILLIAM J. SVP, FINANCE

  • Officer
52,369 2015-08-26 0

MCGILLICUDY CORNELIUS III

  • Director
25,579 2014-01-08 0

CONNELLY JAMES P

  • Director
80,513 2013-08-27 0

STOLTENBERG LAURA S CHIEF COMMERCIAL OFFICER

  • Officer
27,273 2013-03-19 0

KRAYACICH JOHN M SVP, SALES AND MARKETING

  • Officer
4,500 2011-03-15 0

BERGER BARRY M SVP, CHIEF MEDICAL OFFICER

  • Officer
60,552 2010-01-07 0

CARELLI CHARLES R JR SVR, CFO, TREASURER & SECRETAR

  • Officer
0 2009-03-31 0

SINGER MICHAEL E

  • Director
540,193 2008-12-12 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JOHNSON SCOTT C. - Officer SVP - RESEARCH AND DEVELOPMENT

2019-09-12 S 3,527 $108.63 d 12,311 12,504.00 direct

JOHNSON SCOTT C. - Officer SVP - RESEARCH AND DEVELOPMENT

2019-09-11 M 7,500 a 15,838 12,504.00 direct

JOHNSON SCOTT C. - Officer SVP - RESEARCH AND DEVELOPMENT

2019-09-11 M 7,500 d 15,000 12,504.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments